Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modifications of the Triaminoaryl Metabophore of Flupirtine and Retigabine Aimed at Avoiding Quinone Diimine Formation
Konrad W. Wurm, Frieda‐Marie Bartz, Lukas Schulig, et al.
ACS Omega (2022) Vol. 7, Iss. 9, pp. 7989-8012
Open Access | Times Cited: 16

Showing 16 citing articles:

Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies
Tingting Hu, Jifa Zhang, Jiaxing Wang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4434-4467
Closed Access | Times Cited: 25
Deep Learning Algorithm Based on Molecular Fingerprint for Prediction of Drug‐Induced Liver Injury
Qiong Yang, Shuwei Zhang, Li Yan
Toxicology (2024) Vol. 502, pp. 153736-153736
Closed Access | Times Cited: 6
Green electrosynthesis of drug metabolites
Ridho Asra, Alan M. Jones
Toxicology Research (2023) Vol. 12, Iss. 2, pp. 150-177
Open Access | Times Cited: 13
In Silico Methods for the Discovery of Kv7.2/7.3 Channels Modulators: A Comprehensive Review
Claudio Stagno, Francesca Mancuso, Tania Ciaglia, et al.
(2024)
Open Access | Times Cited: 2
Carba Analogues of Flupirtine and Retigabine with Improved Oxidation Resistance and Reduced Risk of Quinoid Metabolite Formation
Konrad W. Wurm, Frieda‐Marie Bartz, Lukas Schulig, et al.
ChemMedChem (2022) Vol. 17, Iss. 16
Open Access | Times Cited: 10
Advances in the design and development of chemical modulators of the voltage-gated potassium channels K V .4 and K V .5
Jana Lemke, Maik Gollasch, D Tsvetkov, et al.
Expert Opinion on Drug Discovery (2024)
Closed Access | Times Cited: 1
Development of an automated screen for Kv7.2 potassium channels and discovery of a new agonist chemotype
Ciria C. Hernández, Rahilla A. Tarfa, Jose Miguel I. Limcaoco, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 71, pp. 128841-128841
Open Access | Times Cited: 8
A graphite furnace‐atomic absorption spectrometry‐based rubidium efflux assay for screening activators of the Kv7.2/3 channel
Frieda‐Marie Bartz, Kristin Beirow, Konrad W. Wurm, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 5
Open Access | Times Cited: 4
Three-Step Synthesis of the Antiepileptic Drug Candidate Pynegabine
Yi-Jing Sun, Ya‐Ling Gong, Shi‐Chao Lu, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 4888-4888
Open Access | Times Cited: 3
Replacing the oxidation‐sensitive triaminoaryl chemotype of problematic KV7 channel openers: Exploration of a nicotinamide scaffold
Konrad W. Wurm, Frieda‐Marie Bartz, Lukas Schulig, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 2
Open Access | Times Cited: 5
Structure‐Activity Relationships of Flupirtine Analogues for Liver Esterase‐Mediated Cleavage of the 4‐Fluorobenzylamine Moiety and Its Possible Relevance to Liver Toxicity
Kristin Beirow, Julia Jedamzik, Lukas Schulig, et al.
ChemMedChem (2023) Vol. 18, Iss. 14
Open Access | Times Cited: 2
In Silico Methods for the Discovery of Kv7.2/7.3 Channels Modulators: A Comprehensive Review
Claudio Stagno, Francesca Mancuso, Tania Ciaglia, et al.
Molecules (2024) Vol. 29, Iss. 13, pp. 3234-3234
Open Access
Discovery of a novel KV7.2/7.3 channels agonist for the treatment of neuropathic pain
Kun Qian, Jingyan Zhou, Jiaying Xiong, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116953-116953
Closed Access
Attenuation of Epileptogenesis and Cognitive Deficits by a Selective and Potent Kv7 Channel Opener in Rodent Models of Seizures
Xiao-fei Zhuang, Yuxue Liu, Zhihong Yang, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 2, pp. 315-325
Closed Access | Times Cited: 3
Metabophore-mediated retro-metabolic (‘MeMeReMe’) approach in drug design
S. Balaji
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103736-103736
Closed Access | Times Cited: 1
Development of an Automated Screen for Kv7.2 Potassium Channels and Discovery of a New Agonist Chemotype
Ciria C. Hernández, Rahilla A. Tarfa, Jose Miguel I. Limcaoco, et al.
SSRN Electronic Journal (2022)
Closed Access
Page 1

Scroll to top